Technologies
Lexicon Pharmaceuticals Inc (LXRX) Stock’s Detailed Analysis
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has a beta value of 1.09 and has seen 2.65 million shares traded in the last trading session. The company, currently
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has a beta value of 1.09 and has seen 2.65 million shares traded in the last trading session. The company, currently
© 2024, Powered by Smart TechOne